I’m pretty educated on the pharmaceutical industry for someone who doesn’t work anywhere near it, and last week’s Econtalk taught me a lot. Here’s a teaser.
Developers of new medication are granted a limited term to sell that medication without competition, which generally makes the price higher. This is useful because it creates an incentive for inventing new drugs. But it’s costly, because the incentive is money consumers wouldn’t otherwise spend. Sometimes companies claim patent protection for bullshit patents, just like the software industry. Challenging these patents is costly; to incentivize generic manufacturers to do so, the government grants them a limited monopoly if a they win. For six months only they and the inventor can sell the product.
Only the count starts when the second manufacturer brings their version to market, not when they win the case. If they don’t release a product no one else can either, even if the drug moves off patent in the meantime. Unsurprisingly, pharmaceutical research companies began paying off generic manufacturers to essentially win lawsuits and then never release a generic, thus extending their monopoly past the patent expiration.
Courts have mostly struck that down at this point, and companies have moved to either more subtle rent seeking (“how about we just pay you to manufacture the drug for us?”) or more antagonistic actions…
Dd you know that you can’t have a generic for a name-brand drug that’s no longer on the market? I mean, you can, but doctors don’t write prescriptions for generics, they write it for the name brand and the pharmacist gives you the cheapest substitute. But they can only do that if the name brand is theoretically available. If a company, say, tweaks the formula in an absolutely irrelevant way and files a new patent on that, they can completely forestall generic competition until the new patent runs out.
Big pharma, I’m on your side. I defend your monopoly profits more than almost anyone. But you need to cut this shit out.
4 thoughts on “Econtalk on Generic Medications”
Technically, if you know what to ask for, you can get generics for drugs where the name brand is no longer on the market. Lybrel, which is to my knowledge the only birth control pill with no breaks, is not on the market. A prescription for “Lybrel, generic OK” is perfectly fillable, as signified by the fact that I have most of a month’s supply in my purse right now. The people at the pharmacy may give you weird looks, or tell you “Lybrel isn’t available, the generic is all that exists” but they’ll fill it just fine.
Granted I haven’t tried this for a lot of drugs, and one that’s harder for potential patients to find out the existence of and specifically ask for might be harder? I am absolutely not an expert in the field! I just happen to have a generic for an off-market name brand in my purse.
Interesting. I take it you’re in the US? The podcast explicitly says that can’t happen, but you present compelling evidence it does.
Eep! Ah – yeah. I’m in the US. California if it matters, but I have successfully collected this prescription elsewhere in the US without issues. I have had two separate practitioners prescribe this for me – one Ob/Gyn, one primary care – and both had to look it up, but could write the prescription just fine and were perfectly willing to. The only initial information I had was “there’s a birth control pill that has no breaks and I want -that one-“; my primary care looked it up, said “Lybrel,” and we went from there. My primary care may be more accommodating than most people’s, but the Ob/Gyn wasn’t, so… it all seemed pretty straightforward?
Comments are closed.